Craft

Orthofix

Stock Price

$13.5

2024-04-02

Market Capitalization

$505 M

2024-04-02

Revenue

$746.6 M

FY, 2023

Orthofix Summary

Company Summary

Overview
Orthofix is a medical device company focused on musculoskeletal products and therapies. It operates Orthofix Spine and Orthofix Extremities business units. The company develops, manufactures, and distributes reconstruction and regenerative spine and extremity products that empower surgeons to meet the needs of their patients.
Type
Public
Status
Active
Founded
1980
HQ
Lewisville, TX, US | view all locations
Website
http://www.orthofix.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Jon Serbousek

    Jon Serbousek, Director, President, and Chief Executive Officer

    • Kimberley Elting

      Kimberley Elting, Chief Legal and Development Officer

    • Doug Rice

      Doug Rice, Chief Financial Officer

    • Ehab Esmail

      Ehab Esmail, Senior Vice President of Quality, Regulatory and Clinical Affairs

    LocationsView all

    9 locations detected

    • Lewisville, TX HQ

      United States

      3451 Plano Pkwy

    • Sunnyvale, CA

      United States

      501 Mercury Dr

    • Sao Paulo, SP

      Brazil

      Alameda Santos, 1978 - conj 162, 16°andar - Jardim Paulista

    • Arcueil, IDF

      France

      28 Villa Baudran 24

    • Paris, IDF

      France

      259 Rue Saint-Honoré

    • Ottobrunn, Bayern

      Germany

      5 Siemensstraße

    and 3 others

    Orthofix Financials

    Summary Financials

    Revenue (FY, 2023)
    $746.6M
    Gross profit (FY, 2023)
    $486.3M
    Net income (FY, 2023)
    ($151.4M)
    Cash (FY, 2023)
    $33.1M
    EBIT (FY, 2023)
    ($139.1M)

    Footer menu